Biohaven Ltd.
BHVN
$9.24
$0.121.32%
NYSE
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 3.22% | -19.55% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -19.99% | -4.45% | |||
| Operating Income | 19.99% | 4.45% | |||
| Income Before Tax | 12.46% | 10.49% | |||
| Income Tax Expenses | -15.33% | -57.14% | |||
| Earnings from Continuing Operations | 12.47% | 10.61% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 12.47% | 10.61% | |||
| EBIT | 19.99% | 4.45% | |||
| EBITDA | 20.73% | 4.37% | |||
| EPS Basic | 15.31% | 10.99% | |||
| Normalized Basic EPS | 15.42% | 10.69% | |||
| EPS Diluted | 15.31% | 10.99% | |||
| Normalized Diluted EPS | 15.42% | 10.69% | |||
| Average Basic Shares Outstanding | 3.36% | 0.42% | |||
| Average Diluted Shares Outstanding | 3.36% | 0.42% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||